Company Comparison
Millendo Therapeutics vs 10x Genomics
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Millendo Therapeutics | 10x Genomics |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | — | — |
| Founded | — | — |
| Status | Active | Active |
| Last Funding Stage | — | — |
| Total Funding | — | — |
| Valuation | — | — |
What They Build
Millendo Therapeutics
Clinical-stage biopharmaceutical company developing treatments for rare endocrine diseases and hormonal disorders, ceased operations in 2021.
10x Genomics
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Key Investors
Sector Overlap
Both Millendo Therapeutics and 10x Genomics operate in Biotech.
Browse all Biotech companies →